Severe Drug-Induced Skin and Liver Injury from Rivaroxaban-Reference-Cited by-同舟云学术

Severe Drug-Induced Skin and Liver Injury from Rivaroxaban

Published:2015-01-06 Issue:6 Volume:60 Page:1856-1858
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Barrett Patrick,Vuppalanchi Raj,Masuoka Howard,Chalasani Naga

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-014-3504-9.pdf

Reference6 articles.

1. FDA expands use of Xarelto to treat, reduce recurrence of blood clots. 2012. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm326654.htm . Accessed on 9/2/2014.

2. Chaudhari K, Hamad B, Syed BA. Antithrombotic drugs market. Nat Rev Drug Discov. 2014;13:571–572.

3. Boudes PF. The challenges of new drugs benefits and risks analysis: lessons from the ximelagatran FDA Cardiovascular Advisory Committee. Contemp Clin Trials. 2006;27:432–440.

4. Russmann S, Niedrig DF, Budmiger M, et al. Rivaroxaban postmarketing risk of liver injury. J Hepatol. 2014;61:293–300.

5. Liakoni E, Ratz Bravo AE, Terracciano L, et al. Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban. JAMA Intern Med. 2014;174:1683–1686.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Severe hepatopathy following rivaroxaban administration in a dog;Frontiers in Veterinary Science;2024-04-04

2. The negative impact of medications on wound healing;Wound Practice and Research;2024-03

3. Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran – A Case Report;Journal of Asthma and Allergy;2023-10

4. A case of drug reaction with eosinophilia and systemic symptoms (DRESS) due to rivaroxaban;Pathology;2023-07

5. Liver injury from direct oral anticoagulants;World Journal of Hepatology;2023-06-27